BiomX Statistics
Total Valuation
BiomX has a market cap or net worth of $9.77 million. The enterprise value is $9.43 million.
Important Dates
The next estimated earnings date is Tuesday, March 24, 2026, before market open.
| Earnings Date | Mar 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BiomX has 1.59 million shares outstanding. The number of shares has increased by 190.21% in one year.
| Current Share Class | 1.59M |
| Shares Outstanding | 1.59M |
| Shares Change (YoY) | +190.21% |
| Shares Change (QoQ) | +0.29% |
| Owned by Insiders (%) | 4.81% |
| Owned by Institutions (%) | 18.51% |
| Float | 1.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.93 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.63.
| Current Ratio | 1.70 |
| Quick Ratio | 1.40 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -154.50% and return on invested capital (ROIC) is -63.96%.
| Return on Equity (ROE) | -154.50% |
| Return on Assets (ROA) | -48.05% |
| Return on Invested Capital (ROIC) | -63.96% |
| Return on Capital Employed (ROCE) | -158.12% |
| Weighted Average Cost of Capital (WACC) | 8.00% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$655,702 |
| Employee Count | 57 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BiomX has paid $9,000 in taxes.
| Income Tax | 9,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.15% in the last 52 weeks. The beta is 1.66, so BiomX's price volatility has been higher than the market average.
| Beta (5Y) | 1.66 |
| 52-Week Price Change | -64.15% |
| 50-Day Moving Average | 3.50 |
| 200-Day Moving Average | 7.74 |
| Relative Strength Index (RSI) | 58.44 |
| Average Volume (20 Days) | 2,148,039 |
Short Selling Information
The latest short interest is 270,744, so 16.99% of the outstanding shares have been sold short.
| Short Interest | 270,744 |
| Short Previous Month | 64,583 |
| Short % of Shares Out | 16.99% |
| Short % of Float | 21.77% |
| Short Ratio (days to cover) | 0.10 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -33.11M |
| Pretax Income | -37.37M |
| Net Income | -37.38M |
| EBITDA | -30.42M |
| EBIT | -33.11M |
| Earnings Per Share (EPS) | -$28.79 |
Full Income StatementBalance Sheet
The company has $6.92 million in cash and $6.58 million in debt, with a net cash position of $340,000 or $0.21 per share.
| Cash & Cash Equivalents | 6.92M |
| Total Debt | 6.58M |
| Net Cash | 340,000 |
| Net Cash Per Share | $0.21 |
| Equity (Book Value) | 10.49M |
| Book Value Per Share | -5.76 |
| Working Capital | 3.64M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$28.29 million and capital expenditures -$13,000, giving a free cash flow of -$28.31 million.
| Operating Cash Flow | -28.29M |
| Capital Expenditures | -13,000 |
| Free Cash Flow | -28.31M |
| FCF Per Share | -$17.76 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BiomX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -190.21% |
| Shareholder Yield | -190.21% |
| Earnings Yield | -382.62% |
| FCF Yield | -289.78% |
Analyst Forecast
The average price target for BiomX is $26.00, which is 324.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $26.00 |
| Price Target Difference | 324.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -25.58% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 25, 2025. It was a reverse split with a ratio of 1:19.
| Last Split Date | Nov 25, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:19 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
